FI874930A - SYNTHETIC PICORNAVIRUS ANTIGEN. - Google Patents
SYNTHETIC PICORNAVIRUS ANTIGEN. Download PDFInfo
- Publication number
- FI874930A FI874930A FI874930A FI874930A FI874930A FI 874930 A FI874930 A FI 874930A FI 874930 A FI874930 A FI 874930A FI 874930 A FI874930 A FI 874930A FI 874930 A FI874930 A FI 874930A
- Authority
- FI
- Finland
- Prior art keywords
- picornavirus
- amino acid
- synthetic
- specific synthetic
- antigenic
- Prior art date
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
A specific synthetic antigenic peptide that contains a sequence of about 20 amino acid residues corresponding to a certain region of the antigenic picornavirus capsid protein such as the VP1 capsids of foot and mouth disease and poliomyelitis viruses. The region is located at a distance of about 60 to 75 percent of the total amino acid length measured from the amino-terminus. Specific synthetic peptide-containing vaccines that produce antibodies that protect animal hosts from the picornaviruses, as well as antibodies to and diagnostics for Picornavirus antigens, are disclosed.
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36830882A | 1982-04-14 | 1982-04-14 | |
| US36830882 | 1982-04-14 | ||
| US47884783A | 1983-03-25 | 1983-03-25 | |
| US47884783 | 1983-03-25 | ||
| US8300477 | 1983-04-06 | ||
| PCT/US1983/000477 WO1983003547A1 (en) | 1982-04-14 | 1983-04-06 | Synthetic picornavirus antigen |
| FI834590 | 1983-12-14 | ||
| FI834590A FI80601C (en) | 1982-04-14 | 1983-12-14 | FORMULATION OF SYNTHETIC PICORNAVIRUS ANTIGEN. |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI874930A true FI874930A (en) | 1987-11-06 |
| FI874930A0 FI874930A0 (en) | 1987-11-06 |
| FI80466B FI80466B (en) | 1990-02-28 |
| FI80466C FI80466C (en) | 1990-06-11 |
Family
ID=27241107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI874930A FI80466C (en) | 1982-04-14 | 1987-11-06 | Synthetic Picornavirus vaccine and antigen |
Country Status (1)
| Country | Link |
|---|---|
| FI (1) | FI80466C (en) |
-
1987
- 1987-11-06 FI FI874930A patent/FI80466C/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FI80466B (en) | 1990-02-28 |
| FI874930A0 (en) | 1987-11-06 |
| FI80466C (en) | 1990-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI834590A (en) | SYNTHETIC PICORNAVIRUS ANTIGEN. | |
| Laver et al. | Selection of antigenic mutants of influenza viruses. Isolation and peptide mapping of their hemagglutinating proteins | |
| Garwes et al. | Antigenicity of structural components from porcine transmissible gastroenteritis virus | |
| Wang et al. | Effective synthetic peptide vaccine for foot-and-mouth disease in swine | |
| RU2220978C2 (en) | Peptide induction antibodies formation that react with two different bppcc isolates (variants), immunogenic composition, vaccine for prophylaxis against infection with pig reproductive- -respiratory syndrome, antibody, diagnostic set (variants) | |
| BR9912178A (en) | Synthetic peptide vaccines for foot-and-mouth disease | |
| BG98523A (en) | Hla-limited cytotoxic t-lymphocytic (ctl) epitopes of the virus of hepatite b | |
| DK532184A (en) | ANTIGEN AMINO ACID SEQUENCES | |
| SE8604007L (en) | VACCIN AND IMMUNO ANALYSIS FOR PREVENTED IMMUNO CANCEL SYNDROME (AIDS) | |
| NO871313D0 (en) | PROCEDURE FOR THE PREPARATION OF VIRUS VACCINE. | |
| ES2075440T3 (en) | VACCINE AGAINST HEPATITIS B. | |
| EP0090581A3 (en) | Small peptides with the specificity of foot and mouth disease viral antigens | |
| Matsuno et al. | Purification of an outer capsid glycoprotein of neonatal calf diarrhea virus and preparation of its antisera | |
| Chengalvala et al. | Evaluation of adenovirus type 4 and type 7 recombinant hepatitis B vaccines in dogs | |
| ATE310014T1 (en) | HEPATITIS B VACCINE | |
| Lorenzen et al. | Antibody response to VHS virus proteins in rainbow trout | |
| AR004464A1 (en) | A METHOD FOR PRODUCING A PAPILOMAVIRUS CAPSIDE PROTEIN | |
| Zamorano et al. | Induction of anti foot and mouth disease virus T and B cell responses in cattle immunized with a peptide representing ten amino acids of VP1 | |
| Hasony et al. | Antigenicity of mouse hepatitis virus strain 3 subcomponents in C57 strain mice | |
| Ishii et al. | Immunoglobulins produced in response to Japanese encephalitis virus infections of man | |
| SE9202968D0 (en) | NEW PEPTIDES, DIAGNOSTIC ANTIGENS, USE THEREOF, VACCINES AND MEDICAMENTS | |
| RU99108121A (en) | IMMUNOGENOUS PEPTIDES OF FMD VIRUSES | |
| Berninger et al. | Serologic comparison of four isolates of rabbit hemorrhagic disease virus | |
| ES2052370T3 (en) | IMMUNOLOGICALLY ACTIVE PEPTIDES OR POLYPEPTIDES OF PARVOVIRUS B19. | |
| Wang et al. | Immune response to hepatitis A virus capsid proteins after infection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed | ||
| MM | Patent lapsed |
Owner name: SCRIPPS CLINIC AND RESEARCH FOUNDATION |